Success Metrics

Completion Rate
0%(0/4)
Active Trials
3(33%)
Terminated
4(44%)

Phase Distribution

Ph not_applicable
4
44%
Ph early_phase_1
1
11%
Ph phase_1
1
11%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 4 finished

Non-Completion Rate

100.0%

4 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Terminated(4)

Detailed Status

Terminated4
Not yet recruiting2
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
0.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (16.7%)
Phase 11 (16.7%)
N/A4 (66.7%)

Trials by Status

active_not_recruiting111%
not_yet_recruiting222%
recruiting222%
terminated444%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9